Sponsor or institution
Clinical trials and research at Second Affiliated Hospital, Zhejiang University, School of Medicine
As of November 12, 2026, Find a Trial lists 284 clinical trials run by Second Affiliated Hospital, Zhejiang University, School of Medicine that are recruiting, at sites in 4 countries (most in China (284), South Korea (1), United States (1)). 2 were first registered in the last 30 days. By phase: Phase 2 (56), Phase 1 (18), Phase 4 (16), Phase 3 (12). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 284Clinical trials
- 2New in 30 days
- 4Countries
Newest trials
All recruiting trials (newest 150 of 284)
-
Intelligent Video Laryngoscope to Help Emergency Intubations
A smart video laryngoscope with AI is tested to help doctors place tubes in critically ill adults needing emergency intubation.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
Ultrasound-guided nasal bone fracture reduction
This study tests whether using ultrasound to guide nasal bone fracture reduction can improve accuracy and outcomes for people with recent nasal injuries.
-
Simplified Tranexamic Acid Regimen for Trauma with Hemorrhage
This trial tests a simplified TXA dosing approach to see if it safely helps adults with major trauma and significant bleeding.
-
Retrobulbar glucocorticoid injection for retinal light injury
This study tests whether giving a retrobulbar glucocorticoid injection helps people who have retinal damage from bright light.
-
Bevacizumab for severe HHT-related nosebleeds
This study tests whether bevacizumab can help people with hereditary hemorrhagic telangiectasia who have severe nosebleeds.
-
Hyperfractionated radiotherapy for high-proliferation NSCLC
This trial tests whether a boosted, accelerated radiotherapy approach is safe and helps people with highly proliferative non-small cell lung cancer.
-
Memory-Enhanced CAR-T Therapy for Relapsed/Refractory Large B-Cell Lymphoma
This trial tests memory-enhanced 7×19-THEMIS CAR-T cells in adults with relapsed or refractory large B-cell lymphoma to see how safe they are and whether tumors shrink or disappear.
-
Radiotherapy Approach for Poorly Differentiated Early Glottic Cancer
This trial tests whether definitive radiotherapy or postoperative radiotherapy can improve local control for adults with poorly differentiated early-stage glottic squamous cell carcinoma.
-
Postoperative IMRT to reduce recurrence in early glottic cancer involving the anterior commissure
This trial tests whether adding postoperative IMRT after surgery for early-stage glottic cancer with anterior commissure involvement can lower local recurrence.
-
Sintilimab Plus Hypofractionated Radiotherapy Then Chemoradiotherapy for Locally Advanced Head and Neck Cancer
This study tests whether giving sintilimab with a short, high-dose radiotherapy course followed by standard chemoradiotherapy helps people with locally advanced head and neck squamous cell carcinoma.
-
taVNS Therapy for Social Anxiety Disorder
This study tests whether non-invasive taVNS can help reduce social anxiety symptoms in adults with SAD.
-
AI-assisted and traditional workflows for admission diagnosis and management planning
This trial tests whether an AI-agent workflow helps doctors make better admission diagnoses and care plans on simulated cases, compared with plain AI-assisted and traditional workflows.
-
Protective effect of phycocyanin on liver injury after partial hepatectomy
This study tests whether taking phycocyanin around liver surgery can reduce liver injury and help the liver recover in adults with intrahepatic cholangiocarcinoma.
-
Remimazolam versus Midazolam for anesthesia induction in older adults
This observational study compares remimazolam and midazolam when inducing anesthesia in people aged 65 and older undergoing elective non-cardiac surgery to see which provides better stability and safety.
-
Amivantamab with intrathecal pemetrexed for leptomeningeal metastasis from EGFR-mutated lung adenocarcinoma
This study tests whether giving amivantamab with intrathecal pemetrexed is safe and may help treat leptomeningeal metastasis in adults with EGFR-mutant lung cancer.
-
TEER plus electrical cardioversion for severe mitral regurgitation with atrial fibrillation
This study tests whether adding electrical cardioversion to TEER helps people with severe mitral regurgitation and atrial fibrillation to have fewer deaths, hospitalizations for heart failure, and strokes within a year.
-
Auricular point stimulation with dexamethasone vs standard antiemetics for chemo-induced nausea in pancreatic cancer
This study tests whether adding ear acupuncture-style stimulation to dexamethasone can prevent and reduce nausea and vomiting caused by gemcitabine plus paclitaxel in pancreatic cancer patients, compared with the usual antiemetic drugs.
-
Auricular point stimulation with dexamethasone versus standard antiemetics for nausea from trastuzumab deruxtecan
This trial tests whether adding ear acupuncture-style stimulation to dexamethasone can prevent and reduce nausea and vomiting caused by trastuzumab deruxtecan in breast cancer patients, compared with the usual antiemetic regimen.
-
Auricular Point Stimulation With Dexamethasone vs Standard Anti-nausea Medications for Docetaxel‑Cyclophosphamide Therapy
This study tests whether adding ear acupuncture-like stimulation to dexamethasone can match or be as effective as standard antiemetic drugs for preventing nausea and vomiting in people receiving the docetaxel–cyclophosphamide chemotherapy.
-
tRF-31 and HIPK2 in age-related cataract: a look at eye tissue and surgery outcomes
This observational study tests whether the tRF-31/HIPK2 signaling axis in the eye relates to cataract severity in adults with age-related cataract.
-
Intensified adjuvant therapy for high-risk glioblastoma after partial removal or early progression
This study tests whether adding intensified post-surgery treatment helps adults with high-risk glioblastoma live longer without the disease progressing.
-
SKB264 plus Glecirasib in KRAS G12C-mutant NSCLC: first-line phase 2 approach
This phase II study tests whether the drug combination SKB264 and Glecirasib can help people with KRAS G12C-mutant NSCLC as a first-line treatment.
-
Prospective cardiac surgery cohort to improve perioperative care
A multi-center study will test a large, forward-looking database of adults undergoing heart surgery to better understand what affects short- and long-term outcomes.
-
CT-FFR in Chronic Coronary Syndrome: A multicenter look at risk and outcomes
This study tests whether CT-derived fractional flow reserve (CT-FFR) from prior CT scans can help predict 1-year major adverse cardiovascular events in adults with chronic coronary syndrome.
-
Spinal cord stimulation to help arm and leg movement after stroke
This study tests whether a spinal cord stimulator can improve arm and leg movement in adults who had a stroke and still have weak limbs after at least 6 months.
-
Multimodal Cardiac MRI to See How the Heart Is Working
This study tests a comprehensive MRI approach to characterize heart structure and tissue in adults with suspected or confirmed cardiovascular disease.
-
Preventing nausea and vomiting during multi-cycle chemo and immunotherapy in esophageal and lung cancer
This study tests a combination antiemetic with dexamethasone to see if it lowers nausea and vomiting in adults with esophageal or lung cancer receiving several cycles of chemo plus immunotherapy.
-
Culmerciclib plus aromatase inhibitors for early ER-positive/HER2-negative breast cancer
This study tests whether adding culmerciclib to endocrine therapy before surgery helps highly proliferative ER-positive/HER2-negative breast cancer patients see a better response.
-
Focused ultrasound-guided targeted drug delivery with neoadjuvant therapy for HER2-positive breast cancer
This study tests a focused ultrasound–driven drug delivery approach added to neoadjuvant therapy for women with HER2-positive breast cancer to see if it’s feasible, safe, and shows early signs of effectiveness.
-
Fovinaciclib with endocrine therapy and HER2 blockade for HR+/HER2+ early breast cancer
This study tests whether adding fovinaciclib to endocrine therapy and dual HER2 blockade can shrink HR+/HER2+ breast tumors before surgery, with treatment adapted after an early response.
-
Rectosigmoid Lesion Excision vs. Resection in Advanced Ovarian Cancer
This study tests whether removing a rectosigmoid lesion without full bowel resection can be as safe as removing the bowel segment in women with advanced ovarian cancer.
-
Finerenone in patients having TAVI with heart failure
This study tests whether finerenone can help people with heart failure and preserved ejection fraction who are undergoing transcatheter aortic valve implantation.
-
Photon-counting CT for detecting subsegmental pulmonary embolism
This study will see if photon-counting CT finds very small pulmonary emboli more accurately than standard dual-source CT in adults with suspected acute pulmonary embolism.
-
Ear acupressure plus dexamethasone to prevent chemo nausea from docetaxel and cyclophosphamide
This trial will test whether ear acupressure (auricular point stimulation) combined with dexamethasone can prevent or reduce nausea and vomiting in adults receiving docetaxel plus cyclophosphamide after breast cancer surgery.
-
Ear acupressure plus dexamethasone to prevent nausea and vomiting from trastuzumab deruxtecan
This trial will try ear acupressure combined with a standard dose of dexamethasone to prevent or reduce nausea and vomiting in breast cancer patients receiving trastuzumab deruxtecan.
-
Ear acupressure plus dexamethasone to prevent nausea and vomiting during gemcitabine and albumin‑bound paclitaxel treatment for pancreatic cancer
This will see if ear acupressure with bean seeds plus an IV dose of dexamethasone can prevent nausea and vomiting in people with pancreatic cancer receiving gemcitabine combined with albumin‑bound paclitaxel.
-
Higher-dose, less-frequent guselkumab versus the usual dose for moderate-to-severe plaque psoriasis in Chinese adults
This will test whether a higher dose given less often of guselkumab works as well and is as safe as the usual dosing for Chinese adults with moderate-to-severe plaque psoriasis.
-
Butylphthalide for Multiple System Atrophy: tests safety and symptoms
This study tests whether 3-n-butylphthalide capsules can help reduce symptoms in people with multiple system atrophy compared with a placebo.
-
Second infusion of FAP-targeted iCDC for end-stage dilated cardiomyopathy
This study tests whether a second dose of FAP-targeted immunosuppressive CAR-DC therapy can safely improve heart function in adults with end-stage dilated cardiomyopathy who previously had a partial response.
-
Preventive intrathecal thiotepa with standard chemoradiation for high‑risk glioblastoma
This trial tests whether adding six weekly intrathecal injections of thiotepa to standard chemoradiation can lower leptomeningeal spread and improve outcomes for adults with newly diagnosed GBM that contacts the subventricular zone or had ventricular entry during surgery.
-
Brain activation during mirror-hand movements after stroke (fNIRS)
This project uses near-infrared sensors to see if moving the healthy hand while viewing its mirror image changes brain activity in people who had a first stroke within six months and have very weak finger movement.
-
Digital system to detect and prevent disability risk in older adults
This project will test a smartphone-enabled system that looks for early signs of disability and offers tailored prevention and management for people aged 65 and older.
-
Safety and better outcomes with FAP-targeted immunosuppressive dendritic cells in ischemic heart failure
This trial tests whether a patient's own FAP-targeted immunosuppressive dendritic cells can be safely given alongside standard care to help people with ischemic cardiomyopathy.
-
Camrelizumab, chemotherapy and Ivarmacitinib before surgery for resectable esophageal squamous cell carcinoma
This trial tests whether giving camrelizumab with chemotherapy and the JAK inhibitor Ivarmacitinib before surgery can improve outcomes for patients with locally advanced esophageal squamous cell carcinoma that can be removed by operation.
-
Personalized T-cell Therapy iNeo-Vac-T01 for Advanced Colorectal Cancer
This will test a personalized T-cell therapy called iNeo-Vac-T01 in adults with advanced or metastatic colorectal cancer who have not responded to standard treatments.
-
Preoperative spatially fractionated radiation for large limb and trunk soft tissue sarcoma
This trial tests whether a short, five-fraction course of spatially fractionated radiation given before surgery helps adults with large (≥5 cm) limb or trunk soft tissue sarcoma stay disease-free longer.
-
Tracking recovery after arthroscopic shoulder and knee surgeries
This will follow people having routine arthroscopic shoulder or knee surgery to see if patient characteristics, tear details, or surgical choices predict better recovery and function over two years.
-
Guselkumab for adults with Crohn's disease after ustekinumab failure
This study will try guselkumab for adults with moderate to severe Crohn's disease who did not respond to or could not tolerate ustekinumab to see if they reach remission after 52 weeks.
-
Guselkumab plus a JAK inhibitor for difficult-to-treat inflammatory bowel disease
This project will try guselkumab together with a JAK inhibitor in people aged 14–80 whose moderate-to-severe inflammatory bowel disease has not responded to multiple other treatments.
-
Single-cell and spatial mapping of cells in gum tissue from aggressive versus chronic periodontitis
This project tests whether single-cell and spatial transcriptomics plus whole-genome sequencing can find cellular and genetic differences in gum tissue from people with aggressive periodontitis compared with chronic periodontitis and healthy gums.
-
Autologous stem cell transplant with TEAM conditioning for lymphoma at high risk of CNS relapse
This trial tests whether high-dose TEAM chemotherapy followed by an autologous stem cell transplant helps adults with non-Hodgkin lymphoma who are at high risk of the cancer returning in the brain or spinal cord.
-
7T MRI and visual perception markers for severe mood and psychotic disorders
This project tests whether 7‑tesla MRI scans combined with visual perception tests can identify brain markers linked to diagnosis and treatment outcomes in adults with major depressive disorder, bipolar disorder, or schizophrenia.
-
Preoperative ultrasound-guided nerve blocks to reduce pain and help recovery after ankle arthroscopy
This randomized, double-blind trial will test whether preoperative ultrasound-guided popliteal sciatic and saphenous nerve blocks reduce early pain and opioid use and how they affect ankle strength and walking after ankle arthroscopy.
-
Short bursts of noninvasive brain stimulation to the prefrontal cortex for social anxiety
This treatment will test whether daily intermittent theta-burst brain stimulation to the prefrontal cortex can reduce social anxiety symptoms in people with SAD while tracking brain changes with EEG.
-
AI-guided PET/CT method to identify lung cancer subtype and EGFR mutation status
This project uses PET/CT scans and clinical information to try to identify lung cancer subtypes and whether the EGFR gene is mutated in adults with newly diagnosed lung cancer.
-
Decoding Mandarin speech features from brain-surface signals
This project will try to decode imagined Mandarin speech, including lexical tones, from high-density brain-surface (ECoG) signals in adult patients who are having clinically indicated cortical electrode placement.
-
Short-course SBRT plus toripalimab and chemotherapy for chemo-resistant triple-negative breast cancer
This trial will try a short, high-precision course of breast radiation followed by toripalimab with paclitaxel and carboplatin for people whose triple-negative breast cancer did not shrink after initial chemotherapy to see if it can eliminate invasive cancer at surgery.
-
Emactinib sulfate with chemotherapy and adebrelimab given before surgery for advanced head and neck cancer
This trial tests whether giving emactinib plus adebrelimab with nab‑paclitaxel and cisplatin before surgery can shrink tumors or increase complete responses in people with locally advanced head and neck squamous cell carcinoma.
-
J-VALVE versus surgical aortic valve replacement for severe aortic regurgitation
This study will test whether the J‑VALVE transfemoral valve works as well and is as safe as surgical aortic valve replacement in people aged 65 and older with severe native aortic regurgitation.
-
AI-assisted screening for heart valve disease using routine non-contrast chest CT
This will test whether an AI program can spot moderate-to-severe heart valve disease on routine non-contrast chest CT scans in adults.
-
Iparomlimab and Tuvonralimab with short-course radiotherapy and chemotherapy for locally advanced head and neck cancer
This trial will test whether adding the dual PD-1/CTLA-4 antibody Iparomlimab–Tuvonralimab to hypofractionated radiotherapy and chemotherapy helps people with locoregionally advanced head and neck squamous cell carcinoma.
-
Guselkumab vs Ustekinumab for stricturing Crohn's disease
This study will follow adults with moderate-to-severe Crohn's disease and confirmed intestinal strictures to see if treatment with guselkumab or ustekinumab better controls obstructive symptoms and disease activity.
-
TACE with sintilimab, bevacizumab, and ipilimumab N01 for advanced liver cancer
This trial tries a combination of TACE with sintilimab and bevacizumab plus a single dose of ipilimumab N01 given at different times to see if it is safe and helps people with advanced hepatocellular carcinoma whose tumors cannot be removed.
-
Predicting post-surgery treatment for liver cancer using AI and whole-slide images
Aims to see if an AI model based on postoperative tissue images and imaging data can help decide if patients with hepatocellular carcinoma should receive adjuvant therapy after surgery.
-
Gluteal versus ultrasound-guided corticosteroid injections for frozen shoulder
This test will see if a buttock (gluteal) injection of compound betamethasone works as well as an ultrasound-guided steroid injection into the shoulder joint for adults 18–65 with frozen shoulder.
-
Effects of linear accelerator X-rays on red blood cells collected during cancer surgery
This project will test whether X-rays from a linear accelerator change the structure and function of red blood cells collected from adults undergoing cancer surgery.
-
Radiotherapy after surgery for early-stage tongue cancer with high-risk features
This trial tests whether giving radiotherapy after surgery helps people with early-stage tongue squamous cell carcinoma who have certain high-risk features stay cancer-free longer than simple follow-up.
-
Oncolytic vaccinia virus delivering CD19 to create CAR‑T therapy inside the body for relapsed/refractory B‑cell lymphoma
This treatment uses an oncolytic vaccinia virus that delivers a CD19 CAR inside the body to try to treat adults with relapsed or refractory B‑cell lymphoma.
-
Dexamethasone before infliximab for moderate-to-severe Crohn's disease and ulcerative colitis
This project will test whether giving an IV dose of dexamethasone before infliximab infusions prevents allergic reactions in people aged 14–80 with moderate-to-severe Crohn's disease or ulcerative colitis.
-
Fexofenadine to improve recovery after a heart attack
This trial will test whether taking the antihistamine fexofenadine after a recent STEMI heart attack helps reduce heart damage and improve recovery in adults.
-
Leucogen to prevent ribociclib-related low white blood cell counts in early breast cancer
This trial will test whether taking leucogen reduces the chance of severe neutropenia in women with early HR-positive/HER2-negative breast cancer who are starting ribociclib with endocrine therapy.
-
Chemo plus anti-PD-1 therapy and sitagliptin before surgery for locally advanced pMMR colorectal cancer
This trial tests whether adding sitagliptin and an anti‑PD‑1 antibody to standard pre‑surgery chemotherapy can increase tumor shrinkage in adults with locally advanced pMMR colorectal cancer.
-
Leucine plus radiochemotherapy before surgery for locally advanced rectal cancer
This will try whether taking oral leucine along with standard chemoradiotherapy before surgery helps people with locally advanced rectal cancer get a better tumor response.
-
Dual-target CD19/BCMA CAR-T therapy for relapsed or refractory multiple myeloma
This study will try a CAR-T treatment that targets both CD19 and BCMA to see if it helps people whose multiple myeloma has returned or not responded to prior therapies.
-
iStent with cataract surgery to lower eye pressure in open-angle glaucoma
This trial will see if placing an iStent during cataract surgery helps lower eye pressure in adults with open-angle glaucoma.
-
Finding the best single IV dose of tegileridine for pain after orthopedic surgery
This test tries single IV doses of tegileridine in adults 18–75 having orthopedic surgery to see which dose gives good pain relief after surgery.
-
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with mitomycin or raltitrexed for colorectal cancer spread to the peritoneum
This Phase I study tests PIPAC with mitomycin or raltitrexed alongside standard systemic chemotherapy to see if it is safe and to find the best dose for people whose colorectal cancer has spread to the peritoneum.
-
Intensified HER2-targeted treatment for people with a suboptimal response to initial dual HER2 therapy and chemotherapy
This trial will try stronger targeted drug combinations for people with HER2-positive early breast cancer who don't respond well to initial dual HER2-targeted therapy plus chemotherapy.
-
Intrastromal anti-VEGF injection for corneal neovascularization
We will test whether injecting anti-VEGF medicine into the cornea helps adults with corneal neovascularization caused by herpes simplex keratitis.
-
3D eye modeling to guide diagnosis and treatment of lens problems
This project will try a full 3D eye model made from multiple scans to help surgeons plan treatment for people with complex lens problems such as dislocated, traumatic, or malformed lenses.
-
Presbyopia-correcting intraocular lenses for complex cataracts with anterior segment abnormalities
This trial will test whether presbyopia-correcting intraocular lenses provide better full-range vision and reduce the need for glasses compared with standard monofocal lenses in people having cataract surgery complicated by anterior segment abnormalities.
-
Fecal transplant for chemotherapy and targeted-therapy gut side effects in advanced gastrointestinal cancer
This trial will try oral fecal microbiota transplants (FMT) to see if they reduce chemotherapy or targeted-therapy–related gut symptoms in adults with advanced gastrointestinal cancers.
-
Laparoscopic vs Open Surgery for Colon Cancer in Patients with Visceral Obesity
This study tests whether laparoscopic or open surgery leads to different long-term outcomes for adults with colon cancer and visceral obesity.
-
mRNA vaccine targeting common glioma mutations for recurrent or progressive high-grade glioma
This trial will test an mRNA vaccine that targets common glioma mutations to see if it is safe and helps the immune system fight recurrent or progressive high-grade glioma.
-
ALA-PDT vs LEEP for cervical HSIL/CIN2: a multicenter non-randomized comparison
This study tests whether a non-surgical photodynamic therapy (ALA-PDT) can match the effectiveness of LEEP for HSIL/CIN2 in women.
-
ALA-PDT for cervical LSIL with HPV16/18 in multiple centers
This study tests whether aminolevulinic acid–mediated photodynamic therapy can treat cervical LSIL in people with HPV16/18 compared with just observation.
-
Epidural electrical stimulation to restore walking after spinal cord injury
This study will try epidural electrical stimulation combined with rehabilitation to help people with chronic AIS C–D spinal cord injuries improve their walking ability.
-
TuFEst-LN model test for axillary lymph node status in breast cancer
This study tests whether the TuFEst-LN liquid biopsy model using cfDNA can help identify patients without axillary lymph node metastasis among those planned for upfront surgery, and see if combining TuFEst-LN results with preoperative MRI can predict post-neoadjuvant nodal status.
-
Long-term follow-up for liver transplant recipients and living donors
This project will follow people who receive liver transplants and those who donate part of a liver to see if clinical factors predict complications and long-term health.
-
Do tiny coronary blood vessel problems affect outcomes in dilated cardiomyopathy?
This project will test whether coronary microvascular dysfunction changes long-term outcomes for people with dilated cardiomyopathy.
-
Semaglutide, Tirzepatide, or Metformin to slow biological age in adults with obesity.
This 24-week test gives semaglutide, tirzepatide, or metformin to adults with obesity to see if the drugs slow or reverse accelerated biological (epigenetic) aging.
-
Acupoint herbal patching to relieve qi deficiency and constipation during chemotherapy
This trial tests whether applying herbal patches to acupuncture points can help adults with colorectal cancer who have qi deficiency and constipation while they receive postoperative chemotherapy.
-
Control of anesthesia depth using continuous, non-invasive breath monitoring.
This project tests whether continuous, non-invasive measurements of exhaled sevoflurane and propofol can predict BIS and guide anesthesia depth for adults having combined intravenous–inhalational surgery.
-
Phycocyanin for liver protection in fibrosis and cirrhosis
This trial will test whether a daily phycocyanin supplement can help adults with liver fibrosis or cirrhosis by lowering liver enzymes and improving liver stiffness.
-
Tracking progression and consequences of heart valve disease
This project will follow adults with moderate or worse valve disease to see if clinical tests and imaging can predict when their condition will get worse.
-
LILRA6 CAR-T therapy for relapsed or refractory acute myeloid leukemia.
This trial will test LILRA6-directed CAR-T cell therapy to see if it helps adults (18–75) whose acute myeloid leukemia has returned or not responded to prior treatments.
-
Spirulina to protect the liver and help recovery after partial hepatectomy
This trial will test whether taking spirulina tablets before and after surgery helps people with cholangiocarcinoma protect their liver and recover faster after a partial hepatectomy.
-
AI-powered ECG diagnosis and prognosis for hypertrophic cardiomyopathy
This project will test whether artificial intelligence reading standard 12-lead ECGs can identify different types of hypertrophic cardiomyopathy and tell them apart from look‑alike heart conditions in adults.
-
AK104 plus FOLFIRI with cetuximab or bevacizumab for second-line MSS advanced colorectal cancer
This trial tests whether adding AK104 to FOLFIRI with either cetuximab or bevacizumab helps people with MSS advanced colorectal cancer who progressed after oxaliplatin-based first-line therapy.
-
Portal pressure changes after banding or sclerotherapy for esophageal varices
This will test whether endoscopic band ligation or sclerotherapy changes portal pressure measured by endoscopic ultrasound in adults with cirrhosis and esophagogastric varices.
-
AI-powered multi-omics model to predict breast cancer distant and organ-specific metastasis
This project will test whether combining tumor images, protein data, and gene sequencing with artificial intelligence can predict if and where breast cancer will spread for women who have stored metastatic tissue samples at the hospital.
-
CEA-targeted CAR-T therapy for advanced CEA-positive solid tumors
This trial will try a CEA-targeted CAR-T cell therapy in adults with advanced, CEA-positive non-small cell lung cancer or breast cancer who have progressed after standard treatments.
-
CEA-targeted CAR-T therapy after cytoreductive surgery for peritoneal colorectal cancer
This trial will test whether CEA-targeted CAR-T cells delivered into the abdomen after cytoreductive surgery can help people with colorectal cancer that has spread to the peritoneum.
-
Ivonescimab plus chemotherapy before surgery for resectable esophageal squamous cell cancer
This study tests whether giving Ivonescimab together with chemotherapy before esophageal cancer surgery helps patients see better outcomes than surgery alone.
-
Non-invasive retinal imaging for early diagnosis of Parkinson's disease
This project will test whether a quick, non-invasive eye (fundus) scan can spot early Parkinson's disease in people aged 40–80, including those with early PD, atypical parkinsonism, essential tremor, and healthy volunteers.
-
UX-GIP001 cell therapy for adults with drug-resistant unilateral mesial temporal lobe epilepsy
This treatment will try a one-time transplant of GABAergic interneuron progenitor cells into the affected side of the brain to see if it reduces seizures in adults with drug-resistant unilateral mesial temporal lobe epilepsy.
-
Predicting breast cancer spread with AI-generated spatial pathology maps
This study will try an AI model that uses routine pathology images and clinical data to predict long-term risk of distant metastasis in adult women who had surgery for primary invasive breast cancer.
-
Envafolimab with doxorubicin and ifosfamide for advanced soft tissue sarcoma
This trial will test whether adding envafolimab to doxorubicin and ifosfamide helps people with advanced soft tissue sarcoma respond better.
-
Epidural electrical stimulation to restore function after T11–L3 spinal cord injury
This study will see if epidural electrical stimulation can help people with chronic T11–L3 spinal cord injuries (ASIA B–D) regain motor and sensory function.
-
AI-guided robotic minimally invasive neurosurgery for intracerebral hemorrhage (RAINBOW-ICH)
This trial will test whether AI-assisted, robotic-guided minimally invasive surgery helps adults with spontaneous intracerebral hemorrhage (including basal ganglia, intraventricular, and brainstem types) recover better than conventional care.
-
AI-assisted diagnosis for malignant brain tumors
This project will test an AI system that uses routine preoperative MRI scans to automatically segment and classify malignant brain tumors in adults to help guide diagnosis and care.
-
Stupp treatment plus intrathecal thiotepa for glioblastoma with ventricular or meningeal spread
This trial will test whether adding intrathecal thiotepa to the Stupp regimen and radiotherapy helps adults with glioblastoma that has spread into the brain ventricles or meninges.
-
Spatially fractionated radiotherapy combined with standard treatment for oligoprogressive non-small cell lung cancer.
It tests whether adding spatially fractionated radiotherapy to standard systemic therapy helps people with oligoprogressive non-small cell lung cancer who have progressed after at least one prior systemic treatment.
-
Bispecific B7H3/IL13Ra2 armored CAR-T therapy for recurrent or refractory glioblastoma
This trial will try giving repeated intraventricular injections of EPC-003 bispecific CAR-T cells to adults with B7H3 and/or IL13Ra2 positive recurrent or refractory glioblastoma to see if it is safe and helps control the tumor.
-
Searching for molecular markers linked to radiation-caused dry mouth in head and neck cancer patients
This project will try to find blood, saliva, or tissue markers in adults with head and neck cancer getting radiotherapy to see if those markers can predict who will develop dry mouth.
-
Umbilical cord blood CAR‑NK cells targeting TRBC1/2 for relapsed or refractory peripheral T‑cell lymphoma
This will test whether umbilical cord blood‑derived CAR‑NK cells that target TRBC1/2 are safe and can help people with relapsed or refractory peripheral T‑cell lymphoma.
-
Vebreltinib for advanced or metastatic clear cell sarcoma
This study will try taking vebreltinib pills twice daily to treat people aged 12 and older with unresectable or metastatic clear cell sarcoma who have at least one measurable tumor.
-
tDCS to improve swallowing in Parkinson's disease
This study tests whether adding transcranial direct current stimulation (tDCS) to standard swallowing therapy helps people with Parkinson's disease who have dysphagia.
-
Microneedle intra-arterial injection plus vitrectomy for acute retinal artery occlusion
This trial will try a microneedle intra-arterial thrombolytic injection combined with vitrectomy to restore vision in adults with acute central retinal artery occlusion or macula-involving branch retinal artery occlusion within 7 days of symptoms.
-
Accelerated intermittent theta burst stimulation for neuropathic pain
This project will try accelerated intermittent theta burst stimulation (a rapid form of rTMS) versus standard 10‑Hz rTMS to reduce neuropathic pain in adults with peripheral neuropathy.
-
With versus without internal limiting membrane peeling during surgery for idiopathic epiretinal membrane
This trial will try removing the internal limiting membrane during vitrectomy to see if it improves vision or symptoms for adults with idiopathic epiretinal membrane who have reduced visual acuity or metamorphopsia.
-
Precise diagnosis and treatment system for thyroid-associated eye disease
This project will test whether a deep-learning system using eye images and exams can automatically diagnose, stage, and help plan treatment for people with thyroid-associated ophthalmopathy.
-
Keverprazan plus amoxicillin versus rabeprazole-based therapy for first-line H. pylori treatment
This test will see if Keverprazan plus amoxicillin for 10 or 14 days clears H. pylori in adults as well as or better than the standard rabeprazole quadruple therapy.
-
Bailing Capsules with Guben Kechuan Granules for stable bronchiectasis
This trial will try whether adding Bailing Capsules plus Guben Kechuan Granules to standard Western treatment reduces acute exacerbations in adults with stable bronchiectasis.
-
Epidural electrical stimulation for restoring motor and sensory function after chronic spinal cord injury
This will try epidural electrical stimulation to see if it helps people with chronic spinal cord injuries (ASIA B–D) regain motor and sensory function.
-
Yangtze Delta hereditary ataxia multi-omics and clinical cohort
This project will follow people with hereditary ataxia in the Yangtze River Delta and use multi-omics testing to see if genetic variants, molecular biomarkers, and disease mechanisms can be identified.
-
Orelabrutinib plus Pola‑R‑CHP for untreated non‑GCB diffuse large B‑cell lymphoma
This trial tests whether adding orelabrutinib to the Pola‑R‑CHP chemotherapy improves responses in adults with newly diagnosed non‑GCB diffuse large B‑cell lymphoma.
-
NALIRIFOX as second-line chemotherapy for advanced extrapulmonary high-grade neuroendocrine neoplasms
This trial will try NALIRIFOX (liposomal irinotecan with fluorouracil and oxaliplatin) as a second-line treatment for adults with metastatic extrapulmonary high‑grade neuroendocrine neoplasms who progressed after first‑line therapy.
-
VISOR for removing 1–3 cm kidney and ureter stones
This will test a new device called VISOR to break up and remove 1–3 cm kidney or ureter stones in adults aged 18–80.
-
First-line immunotherapy plus chemotherapy in extensive-stage small cell lung cancer
This study tests whether adding Tafolecimab and Sintilimab to standard chemotherapy can help people with extensive-stage small cell lung cancer.
-
First-line treatment with orelabrutinib plus rituximab for marginal zone lymphoma
This will test whether taking orelabrutinib together with rituximab works and is safe as a first systemic treatment for adults with marginal zone lymphoma.
-
Watching a short video before anti-VEGF eye injections
This trial will test whether watching a brief procedural video before a first anti-VEGF intravitreal injection helps people with retinal diseases feel less anxious and have fewer or smaller subconjunctival hemorrhages.
-
Comparing two treatments for advanced colorectal cancer
This study is testing whether a combination of two cancer treatments works better than another combination for people with advanced colorectal cancer that hasn’t responded to other therapies.
-
Combined CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer
This study is testing a new combination therapy using special immune cells to see if it can help people with advanced non-small cell lung cancer feel better and live longer.
-
Sequential versus initial combination treatment for pulmonary arterial hypertension
This trial tests whether starting with one drug and adding the second later works as well as starting both ambrisentan and tadalafil together for adults with PAH.
-
Using combined iron supplements to reduce blood transfusions in heart surgery patients
This study is testing if a mix of iron supplements and vitamin C can help heart surgery patients with low iron levels need fewer blood transfusions.
-
Combining high-intensity focused ultrasound with immunotherapy and chemotherapy for breast cancer treatment
This study is testing if combining high-intensity focused ultrasound with immunotherapy and chemotherapy can help women with a specific type of breast cancer more than just chemotherapy alone.
-
Ciprofol's effect on low blood pressure during surgery in elderly patients on certain medications
This study is testing if a new anesthetic called ciprofol can help prevent low blood pressure during surgery in older patients who have been taking certain heart medications.
-
Treatment for advanced colorectal cancer using targeted CAR-T and CAR-DC therapies
This study is testing a new combination treatment using special immune cells to see if it can help people with advanced colorectal cancer live longer and feel better.
-
Online positive psychology program to improve mental health and quality of life in Crohn's disease
This trial will try an online positive psychology program to improve mood and quality of life for adults with Crohn's disease who have mild to moderate anxiety or depression.
-
Enhanced treatment for newly diagnosed glioblastoma after surgery
This study is testing a new treatment plan for people with newly diagnosed glioblastoma after surgery to see if a combination of different drugs and higher radiation doses works better than the usual care.
-
Neoadjuvant radiotherapy for unresectable thymoma
This study is testing if giving radiation therapy before surgery helps people with advanced thymoma have better outcomes compared to combining it with chemotherapy.
-
Investigating joint issues in patients with Gitelman Syndrome
This study is trying to see if people with Gitelman Syndrome also have joint problems caused by calcium deposits and how these issues can be managed.
-
FAP-targeted immunosuppressive CAR-DC therapy for end-stage dilated cardiomyopathy
Researchers are testing a new immune-cell therapy to see if it’s safe and helps people with end-stage dilated cardiomyopathy.
-
Using betaine hydrochloride to treat autoimmune gastritis
This study is testing whether betaine hydrochloride can help people with autoimmune gastritis feel better and reduce their health risks.
-
Effect of Blood Management in Bone Tumor Surgery
This study is testing if a blood management technique called acute normovolemic hemodilution can help people having bone tumor surgery avoid anemia and its complications.
-
Combining SBRT and Lenalidomide for treating Solitary Plasmacytoma
This study is testing whether combining a targeted radiation treatment with a medication can help people with a rare type of tumor called solitary plasmacytoma respond better to treatment and live longer without the disease progressing.
-
Reducing brain swelling in patients with large ischemic stroke using a specialized medication
This study is testing a new medication to see if it can help reduce brain swelling in people who have had a large ischemic stroke.
-
Using PCSK9 inhibitors to lower cholesterol in patients with high-risk coronary plaques
This study tests if adding a new cholesterol-lowering medication to standard treatment can help people with high-risk heart plaques avoid serious heart and brain problems.
Showing recruiting studies first, then the newest. Describe your situation to find the ones that fit you.
Quick answers
How many clinical trials run by Second Affiliated Hospital, Zhejiang University, School of Medicine are recruiting right now?
284, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (284 trials), South Korea (1 trial), United States (1 trial), Singapore (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 56, Phase 1: 18, Phase 4: 16, Phase 3: 12. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.